Bioplasty for Vertebral Fractures: Preliminary Results of a Pre-Clinical Study on Goats Using Autologous Modified Skin Fibroblasts

The debate is still ongoing about the long term effects of the mininvasive vertebral augmentation techniques and their usefulness in treating more complex cases where a bone inducing effect more than a merely bone substitution would be suitable, such as the vertebral fractures in young patients. We previously developed a clinically relevant gene therapy approach using modified dermal fibroblasts for inducing bone healing and bone formation in different animal models. The aim of this study is to show the feasibility of a minimally invasive percutaneous intrasomatic ex vivo gene therapy approach to treat thoracolumbar vertebral fractures and anterior column bone defects in a goat model.

[1]  H. Genant,et al.  Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial Fractures , 2010 .

[2]  P. Giannoudis,et al.  Fractures of the hip and osteoporosis: the role of bone substitutes. , 2009, The Journal of bone and joint surgery. British volume.

[3]  F. Michetti,et al.  Ex vivo-transduced autologous skin fibroblasts expressing human Lim mineralization protein-3 efficiently form new bone in animal models , 2008, Gene Therapy.

[4]  Y. Kawaguchi,et al.  Calcium phosphate cement-based vertebroplasty compared with conservative treatment for osteoporotic compression fractures: a matched case-control study. , 2006, Journal of neurosurgery. Spine.

[5]  Adam J Starr,et al.  Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures. , 2003, The Journal of bone and joint surgery. American volume.

[6]  R. Lavery,et al.  Prospective validation of computed tomographic screening of the thoracolumbar spine in trauma. , 2003, The Journal of trauma.

[7]  Gerald R. Williams,et al.  Complications of Thermal Capsulorrhaphy of the Shoulder , 2001, The Journal of bone and joint surgery. American volume.

[8]  G. Zych,et al.  Osteogenic Protein-1 (Bone Morphogenetic Protein-7) in the Treatment of Tibial Nonunions: A Prospective, Randomized Clinical Trial Comparing rhOP-1 with Fresh Bone Autograft* , 2001, The Journal of bone and joint surgery. American volume.

[9]  B. Trapnell,et al.  Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy , 1996, Journal of virology.

[10]  J. Nemzek,et al.  Retroviral Transmission in Bone Allotransplantation: The Effects of Tissue Processing , 1996, Clinical orthopaedics and related research.

[11]  S D Gertzbein,et al.  Scoliosis Research Society. Multicenter spine fracture study. , 1992, Spine.

[12]  A. van der Eb,et al.  A new technique for the assay of infectivity of human adenovirus 5 DNA. , 1973, Virology.

[13]  Anna Tampieri,et al.  Biomimetic Mg-substituted hydroxyapatite: from synthesis to in vivo behaviour , 2008, Journal of materials science. Materials in medicine.

[14]  Anna Tampieri,et al.  Biomimetic Mg- and Mg,CO3-substituted hydroxyapatites: synthesis characterization and in vitro behaviour , 2006 .

[15]  P. Robbins,et al.  Viral vectors for gene therapy. , 1998, Trends in biotechnology.

[16]  M. Chapman,et al.  Morbidity at bone graft donor sites. , 1989, Journal of orthopaedic trauma.